AtasoyN, ErdoganA, YalugI, OzturkU, KonukN, AtikL, UstundagY. A review of liver function tests during treatment with atypical antipsychotic drugs: A chart review study. Prog Neuropsychopharmacol Biol Psychiatr, 31:1255–1260. 2007.
2.
DumckeCW, KragA, MollerS. The heart and the liver. Expert Rev Gastroenterol Hepatol, 3:51–83. 2009.
3.
GaertnerI, AltendorfK, BatraA, GaertnerHJ. Relevance of liver enzyme elevations with four different neuroleptics: A retrospective review of 7,263 treatment courses. J Clin Psychopharmacol, 21:215–222. 2001.
4.
HalesRE, YudofskySC, TalbottJA. The American Psychiatric Press Textbook of Psychiatry. 3rd. Washington, DC: American Psychiatric Press, 1999.
5.
KeanJ, TrzepaczPT, MurrayLL, AbellM, TrexlerL. Initial validation of a brief provisional diagnostic scale for delirium. Brain Inj, 24:1222–1230. 2010.
6.
MartiniDR. Commentary: The diagnosis of delirium in pediatric patients. J Am Acad Child Adolesc Psychiatry, 44:395–398. 2005.
PoolsupN, Li Wan PoA, KnightTL. Pharmacogenetics and psychpharmacotherapy. J Clin Pharm Ther, 25:197–220. 2000.
9.
TurkelSB, JacobsonJR, MunzigE, TavaréCJ. Atypical antipsychotic medications to control symptoms of delirium in children and adolescents. J Child Adolesc Psychopharmacol, 22:126–130. 2012.
10.
ZarebaW, LinDA. Antipsychotic drugs and QT interval prolongation. Psychiatr Q, 74:291–306. 2003.
